Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

STAB - Statera BioPharma Inc

Previous close
0.0006
0   0%

Share volume: 5,122
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
25%
Profitability 25%
Dept financing 18%
Liquidity 75%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
100.00%
2 Year
-98.72%
Key data
Stock price
$0.00
P/E Ratio 
-0.00
DAY RANGE
N/A - N/A
EPS 
-$2.25
52 WEEK RANGE
$0.00 - $0.04
52 WEEK CHANGE
$1.00
MARKET CAP 
43.551 K
YIELD 
N/A
SHARES OUTSTANDING 
72.584 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,122
AVERAGE 30 VOLUME 
$1,372
Company detail
CEO:
Region: US
Website:
Employees: 19
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

statera biopharma’s foundation is based on restoring immune health through the leveraging of complex, pleiotropic beneficial effects. at statera, we embrace the idea that beneficial and safe drugs act as natural analogs in a paracrine fashion, as well as a trans-activator to resolve disease and elicit homeostasis.

Recent news